论文部分内容阅读
单纯糖尿病患者80%死于心血管事件,而2/3冠心病患者合并糖尿病[1]。冠心病患者合并糖尿病,其冠脉病变多为弥漫性,介入治疗效果不理想。药物治疗尤其重要。我科应用立普妥(阿托伐他汀)与辛伐他汀对冠心病并2型糖尿病病人进行治疗观察患者血脂、C反应蛋白的变化发现:TC、LDL-C降
80% of patients with simple diabetes die of cardiovascular events, and 2/3 of patients with coronary heart disease with diabetes mellitus [1]. Coronary heart disease patients with diabetes, the coronary artery lesions are mostly diffuse, interventional treatment is not satisfactory. Medication is especially important. Our department application of Lipitor (atorvastatin) and simvastatin on patients with coronary heart disease and type 2 diabetes were observed in patients with blood lipids, C-reactive protein changes found: TC, LDL-C down